Dialog Box


The Latest News

“This announcement heralds a new era for rare cancer patients. The additional research funding announced today will not only provide tangible improvement and better outcomes, but a beacon of hope for this often neglected group of Australians." More

Rare Cancers Australia has welcomed the December extended listing of Eisai's HALAVEN (eribulin) for the treatment of patients living with advanced liposarcoma. More

Upcoming events

Rare Cancers Australia hosts a vareity of events throughout the year in support of rare cancer awareness. Come along and support our work. See all events.

Campaigns & Fundraising

Support Rare Cancers Australia by donating to a campaign, a fundraiser, or even by setting up your own fundraising page! Find out more.